Stanford Group reiterates its 'buy' rating and $13 price target on Endologix Inc (Nasdaq: ELGX). The analyst said, "the ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE